China Joins ICH in Pursuit of Global Harmonization of Drug Development Standards

THERESA M. MULLIN | August 9, 2017

article image
Increasingly, drug development is a global endeavor. It requires international collaboration to ensure that consistent standards are adopted and adhered to by all drug makers and regulatory authorities, regardless of country of origin or destination. I am pleased to have been in China recently, when the China Food and Drug Administration (CFDA) submitted its membership application to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (also known as the International Council for Harmonisation or ICH). As part of a team of FDA officials whom CFDA invited to share regulatory advancements, we discussed how modernizing regulatory review systems can promote public health.

Spotlight

United Home Healthcare

For nearly a decade, United Home Healthcare of Central Indiana has been leading the way in personalized in-home healthcare services. Our skilled nurses and certified home health aides provide medically necessary in-home care for clients dealing with chronic illness, traumatic injury, frailty, forgetfulness and a number of other health issues. Family owned and operated by the Harris family, the entire United Home Healthcare team knows how much comfort and care within a home setting means to Indiana families.

OTHER ARTICLES

5 Pharma Trends and Their Impact on Packaging

Article | February 27, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Five Ways to Manage Your Trial Effectively in a Fast-Changing Global Environment

Article | February 27, 2020

Over the past half-century, clinical trials have grown increasingly complex. A flood of new data from novel sources combined with more elaborate study designs and tougher regulatory standards have lengthened timelines and hiked costs, contributing to a steady decline of efficiency. It all adds up: Nearly half of all drug launches underperform revenue expectations. And if that isn’t enough, the outbreak of COVID-19 worldwide is having an effect on how life sciences companies operate their businesses, including how clinical trials are conducted. Most clinical trial research organizations have tried to adapt by tweaking a platform here, adding a new app there, but this has only yielded patchwork systems of sites, spreadsheets and dashboards that further burden the process.

Read More

Pfizer Won’t Win the Coronavirus Pharma War

Article | February 27, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

WALGREEN’S IN HOT WATER OVER PHONY PHARMACIST

Article | February 27, 2020

The drugstore chain agreed to pay $7.5 million in fines after an unlicensed pharmacist at several San Francisco Bay locations illegally filled more than 700,000 prescriptions over a ten-year period. According to California prosecutors, Kim Thien Le stole license numbers from other pharmacists to fill prescriptions for Fentanyl, morphine, and other painkillers. Le pleaded guilty to multiple felony impersonation counts. Walgreen’s agreed to the settlement to avoid being charged with consumer fraud in Alameda and Santa Anna Counties. Prosecutors alleged that Walgreen’s failed to verify Le’s license and did not conduct a thorough background check. The company insisted it has taken remedial measures.

Read More

Spotlight

United Home Healthcare

For nearly a decade, United Home Healthcare of Central Indiana has been leading the way in personalized in-home healthcare services. Our skilled nurses and certified home health aides provide medically necessary in-home care for clients dealing with chronic illness, traumatic injury, frailty, forgetfulness and a number of other health issues. Family owned and operated by the Harris family, the entire United Home Healthcare team knows how much comfort and care within a home setting means to Indiana families.

Events